Presbyopia News and Research

RSS

Presbyopia is a medical condition whereby a person loses the ability to see objects clearly at near distance, while maintaining clear vision for long distance vision.

CVDW, Dow Corning collaborate to improve vision correction in children

Dow Corning, a global leader in silicon-based technology, and the Centre for Vision in the Developing World are jointly announcing a collaboration to create an innovative new way to help correct the vision of children in the developing world.

17 Mar 2011

Shamir fourth quarter revenues increase 5.4% to $39.1 million

Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the fourth quarter and year ended December 31, 2010.

14 Mar 2011

NASA certifies Superfocus glasses for astronauts with presbyopia

Superfocus LLC, creators of Superfocus glasses (formerly known as TruFocals) the first adjustable-focus eyeglasses to treat presbyopia, announced today the flight certification of Superfocus by the National Aeronautics and Space Administration (NASA) for use by astronauts on Discovery's final spaceflight (STS-133) and aboard the International Space Station.

25 Feb 2011

Study finds 24% of Spanish drivers have some vision problem

One in four Spanish drivers has a vision problem that affects their driving ability. This is the finding of a study commissioned by the association Visión y Vida in collaboration with the RACC to Aurora Torrents and Jaume Escofet, professors at EUOOT. The aim of the study is to provide objective information on the eyesight of Spanish drivers.

5 Feb 2011

Panasonic to manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses

PixelOptics of Roanoke, Virginia USA announced today that Panasonic Healthcare Co., Ltd. of Ehime, Japan will manufacture electronic lenses for PixelOptics' electronic focusing eyeglasses named emPower!™. The emPower! eyeglasses focus faster than the blink of an eye, have no moving parts, and change focus without making a sound. In March of 2010 at Vision Expo East in New York, New York, Pixel and Panasonic announced that they have been working together for the last two plus years to develop and optimize Pixel's electronic lenses.

From PHC Europe B.V. 13 Dec 2010

Highlights of world's largest ophthalmic education conference

Results of clinical research on new presbyopia treatments now available in Europe-and possibly available soon in the United States-were reported in today's Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology (MEACO). The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference and is in session October 16 through 19 at McCormick Place, Chicago.

20 Oct 2010

ReVision Optics completes enrollment, initial follow up in PresbyLens Phase I clinical trial for presbyopia

ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.

9 Sep 2010

Alcon second-quarter global sales increase 12.5% to $1.89 billion

Alcon, Inc. reported that global sales rose 12.5 percent to $1.89 billion for the second quarter of 2010, or 11.3 percent excluding the impact of foreign exchange fluctuations and acquisitions. Revenue from acquisitions added 40 basis points to sales growth in the quarter, while foreign currency fluctuations added 80 basis points of growth.

27 Jul 2010

HOYA, Adoptics partner to develop shape-changing accommodating intraocular lens

HOYA announced today that the Company has formed a strategic partnership with Adoptics (Switzerland) through an investment that will fund the development of a shape-changing accommodating intraocular lens (AIOL).

21 Jul 2010

ReVision Optics receives $35 million in capital funding

ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received $35 million in capital funding. The Lake Forest, Calif.-based firm specializes in the research, development and manufacturing of custom products to correct and maintain near vision.

26 May 2010

FDA grants LensAR Laser System 510(k) clearance for use in anterior capsulotomy during cataract surgery

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced that the company has received 510(k) clearance from the FDA for use of the LensAR Laser System for anterior capsulotomy during cataract surgery.

18 May 2010

Shamir first-quarter revenue up 18.2% to $40.1 million

Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the first quarter ended March 31, 2010.

10 May 2010

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott today announced financial results for the first quarter ended March 31, 2010.

21 Apr 2010

ReVision Optics initiates US clinical trial of PresbyLens corneal inlay

ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.

9 Apr 2010

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

8 Apr 2010

Vision CRC scientists discover new technology to control myopia

Scientists from the Vision Cooperative Research Centre in Australia today announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners - the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

31 Mar 2010

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.

26 Mar 2010